What is NDC 70771-1818?

70771-1818 is the product NDC for Levothyroxine Sodium, Levothyroxine sodium anhydrous 100 ug/5mL injection, powder, lyophilized, for solution, listed with the FDA by Zydus Lifesciences Limited. It has 1 package NDC, shown above in 10- and 11-digit form.

What is the active ingredient?

Levothyroxine sodium anhydrous.

Zydus Lifesciences Limited, NDC labeler code 70771. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Levothyroxine Sodium?

521 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Levothyroxine Sodium NDC 70771-1818 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)70771-1818Labeler and product segments. Claims need a package NDC.

Product NDC at billing width70771-1818Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
70771-1818-1	70771181801	1 VIAL, SINGLE-DOSE in 1 CARTON (70771-1818-1) / 5 mL in 1 VIAL, SINGLE-DOSEMarketed from Nov 1, 2024

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Levothyroxine Sodium
Generic name (nonproprietary): levothyroxine sodium
Active ingredients: Levothyroxine sodium anhydrous — 100 ug/5mL
Dosage form: Injection, Powder, Lyophilized, For solution
Route: Intravenous
Labeler: Zydus Lifesciences LimitedNDC labeler code 70771
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 217066
Marketing start: Nov 1, 2024
Listing expires: Dec 31, 2026
Other FDA classes: Thyroxine (Chemical structure)
Identifiers: Product ID 70771-1818_09597387-9fda-47b3-8f60-51929fbfe54bSPL ID 09597387-9fda-47b3-8f60-51929fbfe54b
Pharmacologic class: l-Thyroxine

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N470771181801 followed by a unit qualifier and the quantity

Package 70771-1818-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

The FDA listing for this product does not reference a label (SPL) set.

About NDC 70771-1818

What is NDC 70771-1818?: 70771-1818 is the product NDC for Levothyroxine Sodium, Levothyroxine sodium anhydrous 100 ug/5mL injection, powder, lyophilized, for solution, listed with the FDA by Zydus Lifesciences Limited. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Levothyroxine Sodium.
What is the active ingredient?: Levothyroxine sodium anhydrous.
Who is the labeler?: Zydus Lifesciences Limited, NDC labeler code 70771. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Levothyroxine Sodium?: 521 other product NDCs are listed under this name. See all Levothyroxine Sodium NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Levothyroxine Sodium NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Levothyroxine Sodium	Levothyroxine sodium .05 mg/1	TabletOral	Coupler LLC	67046-0819	67046-0819-03
Levothyroxine Sodium	Levothyroxine sodium .137 mg/1	TabletOral	Coupler LLC	67046-0972	67046-0972-03
Levothyroxine Sodium	Levothyroxine sodium .2 mg/1	TabletOral	Coupler LLC	67046-0387	67046-0387-03
Levothyroxine Sodium	Levothyroxine sodium .125 mg/1	TabletOral	Coupler LLC	67046-0951	67046-0951-03
Levothyroxine Sodium	Levothyroxine sodium 100 ug/1	TabletOral	Coupler LLC	67046-1679	67046-1679-03
Levothyroxine Sodium	Levothyroxine sodium .175 mg/1	TabletOral	Coupler LLC	67046-0517	67046-0517-03
Levothyroxine Sodium	Levothyroxine sodium .15 mg/1	TabletOral	Coupler LLC	67046-0515	67046-0515-03
Levothyroxine Sodium	Levothyroxine sodium .1 mg/1	TabletOral	Coupler LLC	67046-0569	67046-0569-03
Levothyroxine Sodium	Levothyroxine sodium .075 mg/1	TabletOral	Coupler LLC	67046-0801	67046-0801-03
Levothyroxine Sodium	Levothyroxine sodium .112 mg/1	TabletOral	Coupler LLC	67046-0290	67046-0290-03

All 522 Levothyroxine Sodium NDCs

Other NDCs under ANDA 217066

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 217066
Product	Strength	Form · route	Labeler	Product NDC
Levothyroxine Sodium	Levothyroxine sodium anhydrous 100 ug/5mL	Injection, Powder, Lyophilized, For solutionIntravenous	Zydus Pharmaceuticals USA Inc.	70710-1833
Levothyroxine Sodium	Levothyroxine sodium anhydrous 200 ug/5mL	Injection, Powder, Lyophilized, For solutionIntravenous	Zydus Pharmaceuticals USA Inc.	70710-1834
Levothyroxine Sodium	Levothyroxine sodium anhydrous 500 ug/5mL	Injection, Powder, Lyophilized, For solutionIntravenous	Zydus Pharmaceuticals USA Inc.	70710-1835